Screener
Spyre Therapeutics, Inc. SYRE Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 8, 2025. Open the filing →
- Filed
- May 8, 2025
- Fiscal quarter
- Q1 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0001636282-25-000049
FAQ
- What is Spyre Therapeutics, Inc.'s net margin?
- Spyre Therapeutics, Inc. (SYRE) reported net margin of -52,939.7% in Q1 2024.
- How has Spyre Therapeutics, Inc.'s net margin changed year-over-year?
- Spyre Therapeutics, Inc.'s net margin decreased by 692.7% year-over-year, from -6,678.2% to -52,939.7%.
- What is the long-term trend for Spyre Therapeutics, Inc.'s net margin?
- Over 2 years (2021 to 2023), Spyre Therapeutics, Inc.'s net margin has grown at a 943.5% compound annual growth rate (CAGR), from -351.1% to -38,238.1%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Spyre Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude